“…Alternatively, optineurin might alter NFκB activity (Sudhakar, et al, 2009, Zhu, et al, 2007). Signaling components of the NFκB pathway, such as TNFα and TBK1, are also associated with glaucoma and interacts with optineurin (Klingseisen, et al, 2012, Morton, et al, 2008, Tezel, et al, 2001). Other functions for optineurin include: a K63-polyubiquitin-chain binding protein (Nagabhushana, et al, 2011, Zhu, et al, 2007), a negative checkpoint for cytokinesis (Kachaner, et al, 2012), and an autophagy/mitophagy receptor (Korac, et al, 2013, Wild, et al, 2011, Wong and Holzbaur, 2014).…”